[ad_1]
The head of the Health Committee of the Iranian Parliament, Hossein Ali Shahriari, said that the Iranian government had not provided the necessary funds to buy the Corona vaccine.
In an interview with the semi-official ISNA agency, published on Friday, Shahriari said that Iran must obtain the necessary money by converting its local currency to the franc currency and then sending it abroad to obtain the vaccine, but was unable to do so.
But Shahriari did not mention the reasons why Iran did not convert its currency to the franc and sent it abroad, while the Iranian government has issued contradictory statements about obtaining the Corona vaccine abroad, according to the report on the website “Radio Farda “.
And before Shahriari, the head of the Central Bank, Abdel Nasser Hemmati, affirmed that the process of transferring money to obtain Corona vaccines faces problems due to the sanctions imposed on Tehran.
On the other hand, the head of the scientific committee of the headquarters of the fight against Corona, Mustafa Qanei, affirmed that Iran does not have the aircraft and the necessary means of transport designated to transport the Pfizer vaccine.
The Pfizer / Biontech vaccine, which is produced in the United States, must be kept at very low temperatures, compared to other Chinese and Russian vaccines.
Accusations of no money inside Iran are reported to come as the Iranian regime continues to pump millions of dollars into its loyalist militias in the Middle East.
The US embassy in Baghdad released a report last year, saying that Khamenei’s wealth is estimated at $ 200 billion, most of which belongs to three institutions: Imam Khomeini’s Order Execution Authority, the Foundation Mostazafan and the Astan Quds Razavi Foundation.
The Khomeini Foundation’s donation income is 27 billion Iranian rials a year, according to data released in 2016.
It is noteworthy that more than 1,140,000 Iranians have been infected with the Corona virus, since the beginning of its spread in the country, while about 53,000 have died.
